𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines

✍ Scribed by Daniela Schilling; Christine Bayer; Anneke Geurts-Moespot; Fred CGJ Sweep; Martin Pruschy; Karin Mengele; Lisa D Sprague; Michael Molls


Book ID
115011021
Publisher
BioMed Central
Year
2007
Tongue
English
Weight
362 KB
Volume
7
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I
✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an

Prognostic value of plasminogen activato
✍ LuciΓ«nne Speleman; Jeroen D. F. Kerrebijn; Maxime P. Look; Cees A. Meeuwis; John πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 2 views

## Abstract ## Background. Tumor cell biological factors, such as urokinase plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor‐1 (PAI‐1), cathepsin D, and c‐myc play a role in tumor invasion, metastasis, and proliferation. In this study, the prognostic importance of thes